2022
DOI: 10.1007/s12640-022-00480-z
|View full text |Cite
|
Sign up to set email alerts
|

Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological Dysfunctions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 144 publications
0
3
0
Order By: Relevance
“…In the present investigation, we aimed to determine how icariin ‘s modification of these signaling pathways may impact the treatment of behavioral and neurochemical abnormalities in a Wistar rat model of ALS induced by MeHg+. Reducing the protein levels of SIRT-1, Nrf-2, and HO-1 in ALS rats by administering MeHg+ for 21 days resulted in multiple neurodegenerative complications [ 11 , 19 , 39 ]. Animal and cell studies show that MeHg+ administration accelerates ALS progression.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the present investigation, we aimed to determine how icariin ‘s modification of these signaling pathways may impact the treatment of behavioral and neurochemical abnormalities in a Wistar rat model of ALS induced by MeHg+. Reducing the protein levels of SIRT-1, Nrf-2, and HO-1 in ALS rats by administering MeHg+ for 21 days resulted in multiple neurodegenerative complications [ 11 , 19 , 39 ]. Animal and cell studies show that MeHg+ administration accelerates ALS progression.…”
Section: Discussionmentioning
confidence: 99%
“…It regulates learning, memory, neurogenesis, inflammation, and ageing. Multiple studies have shown that inhibiting SIRT-1 affects neural plasticity, gene expression, mitochondrial dysfunction, and inflammation [ 11 , 12 ]. Decreased SIRT-1 function and associated causes are responsible for Alzheimer's disease (AD) [ 13 ], schizophrenia [ 14 ], Parkinson's disease (PD) [ 14 , 15 ], and multiple sclerosis (MS) [ 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…The enhancement of the SIRT1-PGC-1α pathway is another signaling route via which melatonin exerts its protective effects, this time mitochondria being the main target, as PGC-1α is known as the master mitochondrial regulator, increasing their biogenesis and function [26]. SIRT1 enhancement by melatonin as a secondary signaling pathway [89] could correct some of the oxidative, mitochondrial, and neurotransmitter imbalances characteristic for depression and other neuropsychiatric disorders [102,103], and contribute to uncovering more of the cellular pathways involved in melatonin's antidepressant-like effect [104,105].…”
Section: Cns Disordersmentioning
confidence: 99%